These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33477363)

  • 1. Plant-Produced Antigen Displaying Virus-Like Particles Evokes Potent Antibody Responses against West Nile Virus in Mice.
    He J; Lai H; Esqueda A; Chen Q
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33477363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Dependent Enhancement Activity of a Plant-Made Vaccine against West Nile Virus.
    Sun H; Acharya D; Paul AM; Lai H; He J; Bai F; Chen Q
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plant-produced antigen elicits potent immune responses against West Nile virus in mice.
    He J; Peng L; Lai H; Hurtado J; Stahnke J; Chen Q
    Biomed Res Int; 2014; 2014():952865. PubMed ID: 24804264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    Vaccine; 2013 Jan; 31(6):873-8. PubMed ID: 23261049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice.
    Yang M; Lai H; Sun H; Chen Q
    Sci Rep; 2017 Aug; 7(1):7679. PubMed ID: 28794424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Plant-Produced Virus-Like Particle Displaying Envelope Protein Domain III Elicits an Immune Response Against West Nile Virus in Mice.
    Stander J; Chabeda A; Rybicki EP; Meyers AE
    Front Plant Sci; 2021; 12():738619. PubMed ID: 34589108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice.
    Spohn G; Jennings GT; Martina BE; Keller I; Beck M; Pumpens P; Osterhaus AD; Bachmann MF
    Virol J; 2010 Jul; 7():146. PubMed ID: 20604940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and efficacy of two types of West Nile virus-like particles different in size and maturation as a second-generation vaccine candidate.
    Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Kurata T; Sata T; Kojima A
    Vaccine; 2010 Sep; 28(40):6588-96. PubMed ID: 20678586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Production of Chimeric Hepatitis B Virus-Like Particles Bearing an Epitope of Hepatitis E Virus Capsid by Transient Expression in
    Zahmanova G; Mazalovska M; Takova K; Toneva V; Minkov I; Peyret H; Lomonossoff G
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33477348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.
    Schumacher J; Bacic T; Staritzbichler R; Daneschdar M; Klamp T; Arnold P; Jägle S; Türeci Ö; Markl J; Sahin U
    J Nanobiotechnology; 2018 Apr; 16(1):39. PubMed ID: 29653575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2.
    Arora U; Tyagi P; Swaminathan S; Khanna N
    J Nanobiotechnology; 2012 Jul; 10():30. PubMed ID: 22794664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric Hepatitis B core virus-like particles harboring SARS-CoV2 epitope elicit a humoral immune response in mice.
    Sazegari S; Akbarzadeh Niaki M; Afsharifar A; Niazi A; Derakhshandeh A; Moradi Vahdat M; Hemmati F; Eskandari MH
    Microb Cell Fact; 2023 Feb; 22(1):39. PubMed ID: 36841778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen.
    Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A
    BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies.
    Chua AJ; Vituret C; Tan ML; Gonzalez G; Boulanger P; Ng ML; Hong SS
    Virol J; 2013 Apr; 10():129. PubMed ID: 23617954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity.
    Diamos AG; Pardhe MD; Sun H; Hunter JGL; Mor T; Meador L; Kilbourne J; Chen Q; Mason HS
    Vaccine; 2020 Apr; 38(18):3455-3463. PubMed ID: 32173095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral and Subcutaneous Immunization with a Plant-Produced Mouse-Specific Zona Pellucida 3 Peptide Presented on Hepatitis B Core Antigen Virus-like Particles.
    Ghasemian K; Broer I; Schön J; Killisch R; Kolp N; Springer A; Huckauf J
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
    Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS
    Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.